{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:20:05Z","timestamp":1763464805982,"version":"3.45.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Development Plan of Jinan Municipal Health Commission","award":["2023-02-137"],"award-info":[{"award-number":["2023-02-137"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03362-0","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:17:28Z","timestamp":1763464648000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low expression\nof MKRN1 promotes leukemia cell proliferation"],"prefix":"10.1186","volume":"30","author":[{"given":"Li","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rujin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yv","family":"Hei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohnad","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haozheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaihui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"1","key":"3362_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-024-00525-x","volume":"10","author":"L Pagliaro","year":"2024","unstructured":"Pagliaro L, Chen SJ, Herranz D, Mecucci C, Harrison CJ, Mullighan CG, et al. Acute lymphoblastic leukaemia. Nat Rev Dis Primers. 2024;10(1):41.","journal-title":"Nat Rev Dis Primers"},{"issue":"Suppl 2","key":"3362_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28371","volume":"68","author":"JH Chang","year":"2021","unstructured":"Chang JH, Poppe MM, Hua CH, Marcus KJ, Esiashvili N. Acute lymphoblastic leukemia. Pediatr Blood Cancer. 2021;68(Suppl 2):e28371.","journal-title":"Pediatr Blood Cancer"},{"issue":"7336","key":"3362_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature09732","volume":"471","author":"H Inuzuka","year":"2011","unstructured":"Inuzuka H, Shaik S, Onoyama I, Gao D, Tseng A, Maser RS, et al. SCF (FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature. 2011;471(7336):104\u20139.","journal-title":"Nature"},{"issue":"13","key":"3362_CR4","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1182\/blood-2011-06-358911","volume":"119","author":"BB Chen","year":"2012","unstructured":"Chen BB, Glasser JR, Coon TA, Zou C, Miller HL, Fenton M, et al. F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation. Blood. 2012;119(13):3132\u201341.","journal-title":"Blood"},{"issue":"26","key":"3362_CR5","doi-asserted-by":"publisher","first-page":"6695","DOI":"10.1182\/blood-2008-07-166835","volume":"113","author":"JM Terme","year":"2009","unstructured":"Terme JM, Lhermitte L, Asnafi V, Jalinot P. TGF-beta induces degradation of TAL1\/SCL by the ubiquitin-proteasome pathway through AKT-mediated phosphorylation. Blood. 2009;113(26):6695\u20138.","journal-title":"Blood"},{"issue":"5","key":"3362_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc9781","volume":"7","author":"S Srivastava","year":"2021","unstructured":"Srivastava S, Sahu U, Zhou Y, Hogan AK, Sathyan KM, Bodner J, et al. NOTCH1-driven UBR7 stimulates nucleotide biosynthesis to promote T cell acute lymphoblastic leukemia. Sci Adv. 2021;7(5):eabc9781.","journal-title":"Sci Adv"},{"issue":"5","key":"3362_CR7","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/s41375-019-0653-z","volume":"34","author":"S Rodriguez","year":"2020","unstructured":"Rodriguez S, Abundis C, Boccalatte F, Mehrotra P, Chiang MY, Yui MA, et al. Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL. Leukemia. 2020;34(5):1241\u201352.","journal-title":"Leukemia"},{"issue":"5","key":"3362_CR8","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.3390\/ijms23052755","volume":"23","author":"M Lejman","year":"2022","unstructured":"Lejman M, Cha\u0142upnik A, Chilimoniuk Z, Dobosz M. Genetic biomarkers and their clinical implications in B-cell acute lymphoblastic leukemia in children. Int J Mol Sci. 2022;23(5):2755.","journal-title":"Int J Mol Sci"},{"key":"3362_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.862206","volume":"12","author":"T Wang","year":"2022","unstructured":"Wang T, Liu W, Wang C, Ma X, Akhtar MF, Li Y, et al. MRKNs: gene, functions, and role in disease and infection. Front Oncol. 2022;12:862206.","journal-title":"Front Oncol"},{"issue":"1","key":"3362_CR10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13059-019-1814-0","volume":"20","author":"A Hildebrandt","year":"2019","unstructured":"Hildebrandt A, Br\u00fcggemann M, R\u00fcckl\u00e9 C, Boerner S, Heidelberger JB, Busch A, et al. The RNA-binding ubiquitin ligase MKRN1 functions in ribosome-associated quality control of poly (A) translation. Genome Biol. 2019;20(1):216.","journal-title":"Genome Biol"},{"issue":"1","key":"3362_CR11","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1038\/s41467-018-05721-4","volume":"9","author":"MS Lee","year":"2018","unstructured":"Lee MS, Han HJ, Han SY, Kim IY, Chae S, Lee CS, et al. Loss of the E3 ubiquitin ligase MKRN1 represses diet-induced metabolic syndrome through AMPK activation. Nat Commun. 2018;9(1):3404.","journal-title":"Nat Commun"},{"key":"3362_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9360339","volume":"2021","author":"X Bai","year":"2021","unstructured":"Bai X, Yang H, Pu J, Zhao Y, Jin Y, Yu Q. MKRN1 ubiquitylates p21 to protect against intermittent hypoxia-induced myocardial apoptosis. Oxid Med Cell Longev. 2021;2021:9360339.","journal-title":"Oxid Med Cell Longev"},{"issue":"11","key":"3362_CR13","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.3390\/v12111322","volume":"12","author":"Z Hajikhezri","year":"2020","unstructured":"Hajikhezri Z, Darweesh M, Akusj\u00e4rvi G, Punga T. Role of CCCH-type zinc finger proteins in human adenovirus infections. Viruses. 2020;12(11):1322.","journal-title":"Viruses"},{"issue":"14","key":"3362_CR14","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/emboj.2009.164","volume":"28","author":"EW Lee","year":"2009","unstructured":"Lee EW, Lee MS, Camus S, Ghim J, Yang MR, Oh W, et al. Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis. EMBO J. 2009;28(14):2100\u201313.","journal-title":"EMBO J"},{"key":"3362_CR15","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/ncomms1981","volume":"3","author":"EW Lee","year":"2012","unstructured":"Lee EW, Kim JH, Ahn YH, Seo J, Ko A, Jeong M, et al. Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis. Nat Commun. 2012;3:978.","journal-title":"Nat Commun"},{"issue":"1","key":"3362_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13046-023-02788-w","volume":"42","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li QS, Liu HL, Tang HT, Yang HL, Wu DQ, et al. MKRN1 promotes colorectal cancer metastasis by activating the TGF-\u03b2 signalling pathway through SNIP1 protein degradation. J Exp Clin Cancer Res. 2023;42(1):219.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"3362_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3233\/CBM-210559","volume":"36","author":"Y Yang","year":"2023","unstructured":"Yang Y, Luo Y, Huang S, Tao Y, Li C, Wang C. MKRN1\/2 serve as tumor suppressors in renal clear cell carcinoma by regulating the expression of p53. Cancer Biomark. 2023;36(4):267\u201378.","journal-title":"Cancer Biomark"},{"key":"3362_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107945","volume":"153","author":"JJ Shi","year":"2024","unstructured":"Shi JJ, Liu YJ, Liu ZG, Chen RY, Wang R, Yu J, et al. Structure-based identification of a potent KDM7A inhibitor exerts anticancer activity through transcriptionally reducing MKRN1 in taxol-resistant and -sensitive triple-negative breast cancer cells. Bioorg Chem. 2024;153:107945.","journal-title":"Bioorg Chem"},{"issue":"5","key":"3362_CR19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41580-021-00448-5","volume":"23","author":"DA Cruz Walma","year":"2022","unstructured":"Cruz Walma DA, Chen Z, Bullock AN, Yamada KM. Ubiquitin ligases: guardians of mammalian development. Nat Rev Mol Cell Biol. 2022;23(5):350\u201367.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"3362_CR20","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","volume":"23","author":"G Dewson","year":"2023","unstructured":"Dewson G, Eichhorn PJA, Komander D. Deubiquitinases in cancer. Nat Rev Cancer. 2023;23(12):842\u201362.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"3362_CR21","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","volume":"21","author":"B Dale","year":"2021","unstructured":"Dale B, Cheng M, Park KS, Kaniskan H, Xiong Y, Jin J. Advancing targeted protein degradation for cancer therapy. Nat Rev Cancer. 2021;21(10):638\u201354.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3362_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12943-018-0857-2","volume":"17","author":"CH Yeh","year":"2018","unstructured":"Yeh CH, Bellon M, Nicot C. FBXW7: a critical tumor suppressor of human cancers. Mol Cancer. 2018;17(1):115.","journal-title":"Mol Cancer"},{"issue":"4","key":"3362_CR23","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/sj.cdd.4402313","volume":"15","author":"PP Kapitsinou","year":"2008","unstructured":"Kapitsinou PP, Haase VH. The VHL tumor suppressor and HIF: insights from genetic studies in mice. Cell Death Differ. 2008;15(4):650\u20139.","journal-title":"Cell Death Differ"},{"issue":"10","key":"3362_CR24","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc2723","volume":"9","author":"AJ Levine","year":"2009","unstructured":"Levine AJ, Oren M. The first 30 years of p53: growing ever more complex. Nat Rev Cancer. 2009;9(10):749\u201358.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3362_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13046-020-01553-7","volume":"39","author":"J Xu","year":"2020","unstructured":"Xu J, Zhang Z, Qian M, Wang S, Qiu W, Chen Z, et al. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-\u03baB activation. J Exp Clin Cancer Res. 2020;39(1):59.","journal-title":"J Exp Clin Cancer Res"},{"issue":"39","key":"3362_CR26","doi-asserted-by":"publisher","first-page":"12442","DOI":"10.1021\/jacs.5b06839","volume":"137","author":"SG Kathman","year":"2015","unstructured":"Kathman SG, Span I, Smith AT, Xu Z, Zhan J, Rosenzweig AC, et al. A small molecule that switches a Ubiquitin ligase from a processive to a distributive enzymatic mechanism. J Am Chem Soc. 2015;137(39):12442\u20135.","journal-title":"J Am Chem Soc"},{"issue":"5","key":"3362_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1182\/blood-2010-02-268862","volume":"116","author":"PG Richardson","year":"2010","unstructured":"Richardson PG, Weller E, Lonial S, Jakubowiak AJ, Jagannath S, Raje NS, et al. Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma. Blood. 2010;116(5):679\u201386.","journal-title":"Blood"},{"key":"3362_CR28","unstructured":"Rong Ren, Zinian Zhao, Qing Zhang. Clinical characteristics and treatment efficacy analysis of children with acute lymphoblastic leukemia combined with invasive fungal infection. Chinese Journal of Pathogenic Biology, 2025;20(01):81\u201385."},{"key":"3362_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.semcancer.2020.10.013","volume":"84","author":"TH Tran","year":"2022","unstructured":"Tran TH, Hunger SP. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities. Semin Cancer Biol. 2022;84:144\u201352.","journal-title":"Semin Cancer Biol"},{"key":"3362_CR30","unstructured":"Junqi Si, Rexi Dan\u00b7Nurmamat, Chen Tian. Research Progress on Gene Mutations in Acute Lymphoblastic Leukemia. Chinese Journal of Clinical Oncology, 2022;49(15):807\u201310."},{"issue":"9","key":"3362_CR31","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1134\/S0006297924090037","volume":"89","author":"EA Guseva","year":"2024","unstructured":"Guseva EA, Emelianova MA, Sidorova VN, Tyulpakov AN, Dontsova OA, Sergiev PV. Diversity of molecular functions of RNA-binding ubiquitin ligases from the MKRN protein family. Biochemistry (Mosc). 2024;89(9):1558\u201372.","journal-title":"Biochemistry (Mosc)"},{"key":"3362_CR32","doi-asserted-by":"publisher","first-page":"7769","DOI":"10.1038\/ncomms8769","volume":"6","author":"MS Lee","year":"2015","unstructured":"Lee MS, Jeong MH, Lee HW, Han HJ, Ko A, Hewitt SM, et al. PI3K\/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis. Nat Commun. 2015;6:7769.","journal-title":"Nat Commun"},{"issue":"1","key":"3362_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","volume":"21","author":"H Zhao","year":"2022","unstructured":"Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M, et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer. 2022;21(1):144.","journal-title":"Mol Cancer"},{"issue":"31","key":"3362_CR34","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1038\/s41388-018-0267-3","volume":"37","author":"HK Lee","year":"2018","unstructured":"Lee HK, Lee EW, Seo J, Jeong M, Lee SH, Kim SY, et al. Ubiquitylation and degradation of adenomatous polyposis coli by MKRN1 enhances Wnt\/\u03b2-catenin signaling. Oncogene. 2018;37(31):4273\u201386.","journal-title":"Oncogene"},{"key":"3362_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100786","volume":"48","author":"B Xu","year":"2021","unstructured":"Xu B, Hu R, Liang Z, Chen T, Chen J, Hu Y, et al. Metabolic regulation of the bone marrow microenvironment in leukemia. Blood Rev. 2021;48:100786.","journal-title":"Blood Rev"},{"issue":"1","key":"3362_CR36","doi-asserted-by":"publisher","first-page":"19173","DOI":"10.1038\/s41598-020-76157-4","volume":"10","author":"D Anderson","year":"2020","unstructured":"Anderson D, Skut P, Hughes AM, Ferrari E, Tickner J, Xu J, et al. The bone marrow microenvironment of pre-B acute lymphoblastic leukemia at single-cell resolution. Sci Rep. 2020;10(1):19173.","journal-title":"Sci Rep"},{"key":"3362_CR37","unstructured":"Min Yang, Yansha Pan, Changling Zhang, Hongying Chen, Qulian Guo, Wenjun Liu. Baseline data of childhood acute lymphoblastic leukemia and the correlation of early treatment response with prognosis. Tianjin Medical Journal, 2024; 52(09):954\u20138."},{"key":"3362_CR38","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.923271","volume":"26","author":"R Zhang","year":"2020","unstructured":"Zhang R, Zhu H, Yuan Y, Zhao J, Yang X, Tian Z. Risk factors for relapse of childhood B cell acute lymphoblastic leukemia. Med Sci Monit. 2020;26:e923271.","journal-title":"Med Sci Monit"},{"issue":"3","key":"3362_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031054","volume":"21","author":"A Kruse","year":"2020","unstructured":"Kruse A, Abdel-Azim N, Kim HN, Ruan Y, Phan V, Ogana H, et al. Minimal residual disease detection in acute lymphoblastic leukemia. Int J Mol Sci. 2020;21(3):1054.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"3362_CR40","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1080\/10428194.2024.2387728","volume":"65","author":"MS Schwartz","year":"2024","unstructured":"Schwartz MS, Muffly LS. Predicting relapse in acute lymphoblastic leukemia. Leuk Lymphoma. 2024;65(13):1934\u201340.","journal-title":"Leuk Lymphoma"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03362-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03362-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03362-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:17:30Z","timestamp":1763464650000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03362-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3362"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03362-0","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research involving human participants was reviewed and approved by the Ethics Committee of the Children\u2019s Hospital Affiliated to Shandong University (SDFE-IRB\/P-2024092). Written informed consent was obtained from all patients prior to their participation in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure statement"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1136"}}